Market Overview

Cardiome Announces CEO Doug Janzen Has Left Company


Cardiome Pharma Corp. (NASDAQ: CRME) today announced that CEO Doug Janzen has left the Company. Dr. William Hunter, a member of the Company's board of directors, has been appointed interim CEO.

Posted-In: News Management


Related Articles (CRME)

View Comments and Join the Discussion!

Partner Center